Published on July 31, 2012 at 11:10 PM
Hyperion Therapeutics, Inc. (NASDAQ:HPTX) announced today the completion
of its initial public offering of 5,000,000 shares of common stock. In
addition, the underwriters of its initial public offering exercised
their over-allotment option in full and purchased an additional 750,000
shares of common stock. All of such shares were sold by Hyperion
Therapeutics at the initial public offering price of $10.00 per share.
Leerink Swann LLC and Cowen and Company, LLC acted as joint book-running
managers for the proposed offering, and Needham & Company, LLC acted as
co-manager of the offering.
Source: Hyperion Therapeutics